- Feature Paper
- Article
Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
- Alireza Morovat,
- Gayani Weerasinghe,
- Victoria Nesbitt,
- Monika Hofer,
- Thomas Agnew,
- Geralrine Quaghebeur,
- Kate Sergeant,
- Carl Fratter,
- Nishan Guha and
- Joanna Poulton
- + 1 author
Recent work has suggested that fibroblast growth factor-21 (FGF-21) is a useful biomarker of mitochondrial disease (MD). We routinely measured FGF-21 levels on patients who were investigated at our centre for MD and evaluated its diagnostic performan...

